Mediwound Stock Options

MDWD Stock  USD 16.90  0.43  2.48%   

Mediwound Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Mediwound Market Cap Over Time

   Market Cap   
       Timeline  

Mediwound Total Stockholder Equity

Total Stockholder Equity

33.17 Million

At present, Mediwound's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting.

Mediwound Corporate Management

Yaron AdvGeneral VPProfile
CPA CPAEx DirectorProfile
Ofer BScChief OfficerProfile
Hani LuxenburgChief OfficerProfile
CWS DPMChief OfficerProfile
When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mediwound. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mediwound. If investors know Mediwound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mediwound listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.16)
Revenue Per Share
2.18
Quarterly Revenue Growth
0.061
Return On Assets
(0.16)
Return On Equity
(0.76)
The market value of Mediwound is measured differently than its book value, which is the value of Mediwound that is recorded on the company's balance sheet. Investors also form their own opinion of Mediwound's value that differs from its market value or its book value, called intrinsic value, which is Mediwound's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mediwound's market value can be influenced by many factors that don't directly affect Mediwound's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mediwound's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mediwound is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mediwound's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.